Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: Tissue parasitism and endogenous IFN-γ as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi

Microbes and Infection

Volumn 2, Issue 8, 2000, Pages 851-866

  Talvani, André ^a,b   Ribeiro, Cristiana S ^a   Aliberti, Júlio C S ^c   Michailowsky, Vladimir ^b   Santos, Paula V A ^b   Murta, Silvane M F ^b   Romanha, Alvaro J ^b   Almeida, Igor C ^c   Farber, Joshua ^d   Lannes Vieira, Joseli ^b   Silva, João S ^c   Gazzinelli, Ricardo T ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Chemokines; Inflammation; Macrophages; Trypanosoma cruzi

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESSENGER RNA; MONOKINE; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; PARASITE LOCALIZATION; PRIORITY JOURNAL; TISSUE LEVEL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0033943272     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00388-9     Document Type: Article

References (60)

1. Burleigh B.A., Andrews N.W. The mechanisms of Trypanosoma cruzi invasion of mammalian cells. Ann. Rev. Microbiol. 49:1995;175-200.
2. . Chagas′ disease. Tropical disease research. Twelfth Programme of UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). 1993;125-125 World Health Organization, Geneva, Switzerland.
3. Rassi A., Luquetti A.O., Rassi Junior A., Rassi S.G., Rassi A.G. Chagas disease - Clinical Features. Wendel S, Brener Z, Camargo M, Rassi A. Chagas Disease (American Trypanosomiasis): its impact on transfusion and clinical medicine. 1992;81-101 International Society of Blood Transfusion Brazil' 92, São Paulo, Brazil.
4. Brener Z. Immune response and immunopathology in T. cruzi infection. Wendel S, Brener Z, Camargo M, Rassi A. Chagas Disease (American Trypanosomiasis): its impact on transfusion and clinical medicine. 1992;International Society of Blood Transfusion Brazil' 92, São Paulo, Brazil.
5. Teixeira A.R.L., Teixeira G., Mac Do V., Prata A. Acquired cell-mediated immunodepression in acute Chagas′disease. J. Clin. Invest. 62:1978;1132-1141.
6. Dias J.C.P. The indeterminate form of human chronic Chagas′disease a clinical epidemiological review. Rev. Soc. Bras. Med. Trop. 22:1989;147-156.
7. Torrico F., Heremans H., Rivera M.T., Van M.E., Billiau A., Carlier Y. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 146:1991;3626-3632.
8. Silva J.S., Morrissey P.J., Gravstein K.H., Mohler K.M., Anderson D., Reed S.G. Interleukin-10 and interferon-(regulation of experimental Trypanosoma cruzi infection. J. Exp. M. 175:1992;169-174.
9. Silva J.S., Vespa G.N.R., Cardoso M.A.G., Aliberti J.C., Cunha F.Q. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi in mice by inducing nitric oxide production in infected IFN-γ-activaded macrophages. Infect. Immun. 63:1995;4862-4867.
10. Aliberti J.C.S., Cardoso M.A.G., Martins G.A., Gazzinelli R.T., Vieira L.Q., Silva J.S. IL-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect. Immun. 64:1996;1961-1967.
11. Hunter C.A., Slifer T., Araujo F.G. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infect. Immun. 64:1996;2381-2386.
12. Camargo M.M., Almeida I.C., Pereira M.E.S., Ferguson M.A.J., Travassos L.R., Gazzinelli R.T. Glycosylphosphatidylinositol anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of pro-inflammatory cytokines by macrophages. J. Immunol. 158:1997;5890-5901.
13. Camargo M.M., Andrade A.C., Almeida I.C., Travassos L.R., Gazzinelli R.T. Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania sp. parasite membranes trigger nitric oxide synthesis as well as microbicidal activity by IFN-γ-primed macrophages. J. Immunol. 159:1997;6131-6139.
14. Abrahamsohn I.A., Coffman R.L. Cytokine and nitric oxide regulation of immunosuppression in Trypanosoma cruzi infection. J. Immunol. 155:1995;3955-3963.
15. Gazzinelli R.T., Oswald I.P., Hieny S., James S., Sher A. The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β Eur. J. Immunol. 22:1992;2501-2506.
16. Vespa G.N.R., Cunha F.Q., Silva J.S. Nitric oxide is involved in the control of Trypanosoma cruzi induced parasitemia and directly kills parasite in vitro. Infect. Immun. 62:1994;5177-5182.
17. Holscher C., Kohler G., Muller U., Mossmann H., Schaub G.A., Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66:1998;1208-1215.
18. Brener Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas′disease. Int. Arch. Allergy Immunol. 114:1997;103-110.
19. Minoprio P., Eisen H., Joskowicz M., Pereira P., Coutinho A. Suppression of polyclonal antibody production in Trypanosoma cruzi-infeted mice by treatment with anti-L3T4 antibodies. J. Immunol. 139:1987;545-550.
20. Tarleton R.L., Koller B.H., Latour A., Postan M. Susceptibility of (-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature. 356:1992;338-340.
21. Tarleton R., Sun J., Zhang L., Postan M. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas′disease. Infect. Immun. 62:1994;1820-1829.
22. Silva L.H., Nussensweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para camundongo branco. Folia Clin. Biol. 20:1953;191-207.
23. Almeida I.C., Ferguson M.A.J., Schenkman S., Travassos L.R. Lytic anti-α-galactosyl antibodies from patients with chronic Chagas′disease recognize novel O-linked oligosaccharides on mucin -like glycosylphosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem. J. 304:1994;793-802.
24. Frederici E.E., Albemann W.H., Neva F.A. Chronic and progressive myocarditis and myositis in C3H mice infected with Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 13:1964;272-280.
25. Michailowsky V., Murta S.M.F., Carvalho-Oliveira L., Pereira M.E.S., Ferreira L.R.P., Brener Z., Romanha A.J., Gazzinelli R.T. Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi. Antimicrob. Agents Chemother. 42:1998;2549-2556.
26. + cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge. Exp. Parasitol. 91:1999;7-19.
27. Gazzinelli R.T., Giese N.A., Morse Iii H.C. In vivo treatment with IL-12 protects mice from immune abnormalities observed during Murine Acquired Immunodeficiency Syndrome (MAIDS). J. Exp. M. 180:1994;2199-2208.
28. Murta S.M.F., Gazzinelli R.T., Brener Z., Romanha A.J. Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Mol. Biochem. Parasitol. 93:1998;203-214.
29. Santos F.R., Pena S.D.J., Epplen J.T. Genetic and population study of an Y-linked tetranucleotide repeat DNA polymorphism. Hum. Genet. 90:1993;655-656.
30. Gazzinelli R.T., Eltoum I., Wynn T.A., Sher A. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151:1993;3672-3681.
31. Gazzinelli R.T., Hieny S., Wynn T.A., Wolf S., Sher A. Interleukin-12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell deficient hosts. Proc. Natl. Acad. Sci. USA. 90:1993;6115-6119.
32. Van Voorhis W.C. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production. J. Immunol. 148:1992;239-248.
33. Buschenfelde C.M.Z., Cramer S., Trumpfheller C., Fleischer B., Frosh S. Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma (IFN-γ) production. Clin. Exp. Immunol. 110:1997;378-385.
34. Jones E.M., Colley D.G., Tostes S., Lopes E.R., Vnencak-Jones C.L., Mc Curley T.L. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am. J. Trop. Med. Hyg. 48:1993;348-357.
35. Higuchi M.L., Brito T., Reis M.M., Barbosa A., Bellotti G., Pereira-Barreto A.C., Pileggi F. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc. Pathol. 2:1993;101-106.
36. Vago A.R., Macedo A.M., Adad S.J., Reis D.D., Corr Aoliveira R. PCR detection of Trypanosoma cruzi in oesophageal tissues of patients with chronic digestive Chagas′disease. Lancet. 348:1996;891-892.
37. Higuchi M.L., Gutierrez P.S., Aiello V.D., Palomino S., Bocchi E., Kalil J., Bellotti G., Pileggi F. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchovs. Arch. [A]. 423:1993;157-160.
38. Reis D.D., Jones E.M., Tostes S., Lopes E.R., Gazzinelli G., Colley D.G., Mc Curley T.L. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-α cells and dominance of granzyme A+, CD8+ lymphocytes. Am. J. Trop. Med. Hyg. 48:1993;637-644.
39. Luster A.D. Chemokines - Chemotatic cytokines that mediate inflammation. New Eng. J. M. 338:1998;345-436.
40. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Ann. Rev. Immunol. 12:1994;593-633.
41. Farber J.M. A macrophage mRNA selectively induced by γ-interferon encodes a member of the platelet factor 4 family of cytokines. Proc. Natl. Acad. Sci. USA. 87:1990;2442-5238.
42. Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T.J., Galanaud P., Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J. Immunol. 154:1995;1870-1878.
43. Vanguri P., Farber J.M. Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine. J. Biol. Chem. 265:1990;15049-15057.
44. Amichay D., Gazzinelli R.T., Kariupiah G., Moench T.R., Sher A., Farber J.M. The genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-γ with patterns of tissue expression that suggest nonredundant roles in vivo. J. Immunol. 157:1996;4511-4520.
45. Farber J.M. MIG and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61:1997;246-257.
46. Taguchi M., Sampath D., Koga T., Castro M., Look D.C., Nakajima S., Holtzman M.J. Patterns for RANTES secretion and intracellular adhesion molecule 1 expression mediate transephithelial T cell traffic based analyses in vitro and in vivo. J. Exp. M. 187:1998;1927-1940.
47. Taub D.D., Lloyd A.R., Conlon K., Wang J.M., Ortaldo J.R., Harada A., Matsushima K., Kelvin D.J., Oppenheim J.J. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. M. 177:1993;1809-1814.
48. Dos Santos R.R., Rossi M.A., Laus J.L., Silva J.S., Savino W., Mengel J. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J. Exp. M. 175:1992;29-39.
49. Tarleton R.L., Zhang L., Downs M.O. "Autoimmune rejection" of neonatal heart transplants in experimental Chagas′disease is a parasite-specific response to infected host tissue. Proc. Natl. Acad. Sci. USA. 94:1997;3932-3937.
50. Tarleton R.L. Trypanosoma cruzi-induced suppression of IL-2 production. I. Evidence for the presence of IL-2-producing cells. J. Immunol. 140:1988;2763-2768.
51. Nabors G.S., Tarleton R.L. Differential control of IFN-γ and IL-2 production during Trypanosoma cruzi infection. J. Immunol. 146:1991;3591-3598.
52. Zhang L., Tarleton R.L. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur. J. Immunol. 26:1996;102-109.
53. + T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α J. Immunol. 157:1996;798-805.
54. Hunter C.A., Ellis-Neyes L.A., Slifer T., Kanaly S., Grunig G., Fort M., Rennick D., Araujo F.G. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158:1997;3311-3316.
55. Weiner H.L., Friedman A., Miller A., Khoury S.J., Al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R.B., Trentham D.E., Hafler D.A. Oral tolerance: immunologic mechanisms and treatment of animals and human organ-specific autoimmune diseases by oral administration of autoantigens. Ann. Rev. Immunol. 12:1994;809-837.
56. Moore K., O′Garra A., Malefyt R.W., Vieira P., Mosmann T.R. Interleukin 10. Ann. Rev. Immunol. 11:1993;165-190.
57. Powell M.R., Morgan J., Guarner J., Colley D.G. Cytokine mRNA levels in the hearts of inbred mice that develop different degrees of cardiomyopathy infection with Trypanosoma cruzi. Parasite Immunol. 20:1998;463-470.
58. Krettli A.U., Brener Z. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies. J. Immunol. 128:1982;2009-2012.
59. Wizel B., Tarleton R.L. The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol. 20:1998;207-216.
60. Bahia-Oliveira L.M.G., Gomes J.A.S., Lemos E.M., Luz Z.M.P., Pereira M.E.S., Coffman R.L., Dias J.C.P., Cançado J.R., Rocha M.O.C., Moreira M.C.V., Gazzinelli G., Corr A-Oliveira R. IFN-γ in human Chagas′disease: protection or pathology? Braz. J. Med. Biol. Res. 31:1998;127-131.